切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2017, Vol. 11 ›› Issue (04) : 255 -259. doi: 10.3877/cma.j.issn.1674-0793.2017.04.010

所属专题: 文献

论著

内窥镜下乳头括约肌切开术治疗胆总管结石合并胰腺炎患者的预后分析
李福荣1,(), 牛福勇1, 李华2   
  1. 1. 719000 陕西省榆林市第一医院肝胆外科
    2. 710004 西安交通大学医学院第二附属医院普外科
  • 收稿日期:2016-12-16 出版日期:2017-08-01
  • 通信作者: 李福荣
  • 基金资助:
    陕西省自然科学基础研究计划项目(2012JQ4016); 西安交通大学基本科研业务费资助项目(Xjj2012072)

Endoscopic sphincterotomy in the treatment of patients of choledocholithiasis combined with pancreatitis

Furong Li1,(), Fuyong Niu1, Hua Li2   

  1. 1. Department of Hepatobiliary Surgery, Yulin First Hospital of Shanxi, Yulin 719000, China
    2. Department of General Surgery, the Second Affiliated Hospital, Medical School of Xi’an Jiaotong University, Xi’an 710004, China
  • Received:2016-12-16 Published:2017-08-01
  • Corresponding author: Furong Li
  • About author:
    Corresponding author: Li Furong, Email:
引用本文:

李福荣, 牛福勇, 李华. 内窥镜下乳头括约肌切开术治疗胆总管结石合并胰腺炎患者的预后分析[J/OL]. 中华普通外科学文献(电子版), 2017, 11(04): 255-259.

Furong Li, Fuyong Niu, Hua Li. Endoscopic sphincterotomy in the treatment of patients of choledocholithiasis combined with pancreatitis[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2017, 11(04): 255-259.

目的

探讨内窥镜下乳头括约肌切开术(EST)后胆囊切除术对胰腺炎患者复发及生存的影响。

方法

选择2010年1月至2015年12月榆林市第一医院行EST的胆总管结石合并胰腺炎患者560例,依据随访情况将患者分为胰腺炎复发组(180例)和未复发组(380例)。结合患者病情决定EST术后胆囊是否切除。采用Kaplan-Meier法和Cox比例风险回归模型进行单因素、多因素生存分析,确定影响胰腺炎患者累积复发率的危险因素,Log-Rank检验比较胆囊切除术对胰腺炎患者复发的影响差异。

结果

560例胰腺炎患者接受EST术后,410例(73.2%)发生高淀粉酶血症,180例(32.1%)复发胰腺炎,其中轻、中、重度胰腺炎各占复发胰腺炎患者的70.0%(126/180)、20.0%(36/180)和10.0%(18/180)。年龄偏小、胰管显影、胆囊切除术、手术时间较长、黄疸、CCI评分较高、脑血管病、糖尿病、高血压、慢性肝病、肥胖症是影响胰腺炎患者接受EST术后复发的危险性因素(P<0.05)。胆囊切除的胰腺炎患者累积复发率和死亡率更低(P<0.05)。

结论

EST术后胆囊切除术可降低胰腺炎患者胰腺炎复发率及死亡率,临床上应推广应用。

Objective

To investigate the recurrence and survival of patients of choledocholithiasis combined with pancreatitis after endoscopic sphincterotomy (EST).

Methods

From January 2010 to December 2015, five hundred and sixty patients with choledocholithiasis and pancreatitis in Yulin First Hospital of Shanxi underwent EST treatment. According to the recurrence of pancreatitis, the patients were divided into two groups: recurrent pancreatitis group (180 cases) and non-recurrent pancreatitis group (380 cases). Depending on the patients’ pancreatitis condition, the gallbladder was removed after EST operation. Univariate and multivariate survival analysis were performed using Kaplan-Meier and Cox proportional hazards regression model to determine the risk factors of cumulative recurrence rate in patients with pancreatitis. Log-Rank test was used to compared the difference of the cumulative recurrence rate.

Results

All the patients received EST, with 410 (73.2%) cases of hyperamylasemia, 126 (22.5%) recurrence of pancreatitis, 36 (6.4%) recurrence of moderate acute pancreatitis and 18 (3.2%) severe pancreatitis. Mild, moderate and severe pancreatitis accounted for 70.0%, 20.0% and 10.0% respectively of the total number of patients with recurrent pancreatitis. Young age, pancreatic duct opacification, cholecystectomy, long operation time, jaundice, higher CCI score, cerebral vascular disease, diabetes, hypertension, chronic liver disease, and obesity were the risk factors of recurrence of postoperative pancreatitis patients received EST (P<0.05). In addition, cumulative recurrence rate and mortality rate were lower in patients with cholecystectomy (P<0.05).

Conclusion

Cholecystectomy can reduce the recurrence rate and mortality of pancreatitis in patients with pancreatitis after EST, and it should be popularized and applied in clinic.

表1 胆总管结石合并胰腺炎患者EST手术前后血清淀粉酶水平变化(U/L,±st检验)
表2 560例胆总管结石合并胰腺炎患者的临床特征(nχ2检验)
表3 胆总管结石合并胰腺炎患者复发胰腺炎
图1 胆囊是否切除对急性胰腺炎患者累积复发率的影响,Log-Rank检验结果显示:与胆囊未切除组相比,胆囊切除组的胰腺炎患者累积复发率更低(P<0.05)
图2 胆囊是否切除对急性胰腺炎患者累积死亡率的影响,Log-Rank检验结果显示:与胆囊未切除组相比,胆囊切除组的胰腺炎患者累积死亡率更低(P<0.05)
[1]
刘礼军,余伟. 腹腔镜联合胆道镜治疗胆囊结石合并胆总管结石的临床疗效分析[J]. 现代诊断与治疗, 2016, 27(9):1642-1643.
[2]
赵昌杰,陈林. 经内镜乳头括约肌小切开联合柱状球囊扩张术治疗胆总管结石36例分析[J]. 中国临床研究, 2016, 29(1):81-83.
[3]
Thabet A, Kalva SP, Liu B, et al. Interventional radiology in pregnancy complications: indications, technique, and methods for minimizing radiation exposure[J]. Radiographics, 2012, 32(1):255-274.
[4]
Kim TK, Kim BS, Kim JH, et al. Diagnosis of intrahepatic stones: superiority of MR cholangiopancreatography over endoscopic retrograde cholangiopancreatography[J]. AJR Am J Roentgenol, 2002, 179(2):429-434.
[5]
Archibald JD, Love JR, McAlister VC. The role of prophylactic cholecystectomy versus deferral in the care of patients after endoscopic sphincterotomy[J]. Can J Surg, 2007, 50(1):19-23.
[6]
郭壮,赵卫东,崔振芹, 等. 内镜下乳头括约肌小切开联合气囊扩张术治疗老年胆总管结石疗效及对血淀粉酶的影响[J]. 中国内镜杂志, 2016, 22(5):80-83.
[7]
周海霞,唐永江,王岚, 等. 肺栓塞远期死亡危险因素及Charlson合并症指数的预测价值[J]. 中华医学杂志, 2016, 96(4):273-276.
[8]
Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus[J]. Gastrointest Endosc, 1991, 37(3):383-393.
[9]
赵程进,钱俊波,葛振明,等. 内镜下乳头括约肌小切开联合球囊扩张术与单独内镜下乳头切开术治疗胆总管结石的随机对照研究[J]. 南京医科大学学报(自然科学版), 2016, 61(10):265-268.
[10]
Gotthardt DN, Rudolph G, Klöters-Plachky P, et al. Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment[J]. Gastrointest Endosc, 2010, 71(3):527-534.
[11]
张群雄. 内镜乳头括约肌切开术后出血的危险因素和止血方法[J]. 实用医学杂志, 2016, 32(4):629-631.
[12]
Sugiyama M, Suzuki Y, Abe N, et al. Endoscopic retreatment of recurrent choledocholithiasis after sphincterotomy[J]. Gut, 2004, 53(12):1856-1859.
[13]
丁世华,吴东海,郭海建, 等. 良性胆胰疾病内镜下乳头括约肌切开术后远期并发症的危险因素分析[J]. 临床肝胆病杂志, 2016, 32(5):918-920.
[14]
汪鹏,张薇,刘枫, 等. 内镜下胰管括约肌切开术后早期并发症的前瞻性研究[J]. 中华消化内镜杂志, 2009, 26(1):23-27.
[15]
吴丽颖,王书海,贾国法, 等. 经十二指肠镜乳头括约肌切开取石术后胆总管结石复发危险因素分析[J/CD]. 中华消化病与影像杂志(电子版), 2015, 5(1):5-9.
[16]
石爱忠,梁宏元,温锋, 等. 恶性梗阻性黄疸经皮经肝胆管造影术中胰管显影与术后并发胰腺炎的相关性[J/CD]. 中国介入影像与治疗学, 2014, 11(7):411-414.
[17]
Nordback I, Pelli H, Lappalainen-Lehto R, et al. The recurrence of acute alcohol-associated pancreatitis can be reduced: a randomized controlled trial[J]. Gastroenterology, 2009, 136(3):848-855.
[18]
Young SH, Peng YL, Lin XH, et al. Cholecystectomy reduces recurrent pancreatitis and improves survival after endoscopic sphincterotomy[J]. J Gastrointest Surg, 2017, 21(2):294-301.
[1] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[2] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[3] 张洁, 罗小霞, 余鸿. 系统性免疫炎症指数对急性胰腺炎患者并发器官功能损伤的预测价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 68-71.
[4] 谢田伟, 庞于樊, 吴丽. 超声引导下不同消融术对甲状腺良性结节体积缩减率、复发率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 80-83.
[5] 王兴, 文阳辉, 姚戈冰, 郭平学, 杨自华. ICG荧光腹腔镜下胆囊切除术的临床应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 663-666.
[6] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[7] 党军强, 杨雁灵, 汪庆强, 尚琳, 朱磊, 项红军. 主动经皮穿刺引流治疗重症急性胰腺炎并发急性坏死物积聚的疗效分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 671-674.
[8] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[9] 皮尔地瓦斯·麦麦提玉素甫, 李慧灵, 艾克拜尔·艾力, 李赞林, 王志, 克力木·阿不都热依木. 生物补片修补巨大复发性腹壁切口疝临床疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 624-628.
[10] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[11] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[12] 赵月, 田坤, 张宗明, 郭震天, 刘立民, 张翀, 刘卓. 降钙素原对老年急性重度胆囊炎发生的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 801-806.
[13] 史清泉, 苗彬, 王烁, 陶琳, 沈晨. miR-181a-5p 靶向ATG5 抑制雨蛙素诱导的大鼠胰腺腺泡细胞AR42J自噬的机制研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 524-530.
[14] 曾明芬, 王艳. 急性胰腺炎合并脂肪肝患者CT 与彩色多普勒超声诊断参数与其病情和预后的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 531-535.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要